<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81727</article-id><article-id pub-id-type="doi">10.7554/eLife.81727</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Computational design of peptides to target Na<sub>V</sub>1.7 channel with high potency and selectivity for the treatment of pain</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-146783"><name><surname>Nguyen</surname><given-names>Phuong T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286843"><name><surname>Nguyen</surname><given-names>Hai M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-286844"><name><surname>Wagner</surname><given-names>Karen M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-171767"><name><surname>Stewart</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202864"><name><surname>Singh</surname><given-names>Vikrant</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286853"><name><surname>Thapa</surname><given-names>Parashar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286854"><name><surname>Chen</surname><given-names>Yi-Je</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286855"><name><surname>Lillya</surname><given-names>Mark W</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286856"><name><surname>Ton</surname><given-names>Anh Tuan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-286857"><name><surname>Kondo</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-286858"><name><surname>Ghetti</surname><given-names>Andre</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-286859"><name><surname>Pennington</surname><given-names>Michael W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5446-3447</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-154307"><name><surname>Hammock</surname><given-names>Bruce</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1408-8317</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-254001"><name><surname>Griffith</surname><given-names>Theanne N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0090-6286</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110218"><name><surname>Sack</surname><given-names>Jon T</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6975-982X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" corresp="yes" id="author-54397"><name><surname>Wulff</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122540"><name><surname>Yarov-Yarovoy</surname><given-names>Vladimir</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2325-4834</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf12"/></contrib><aff id="aff1"><institution content-type="dept">Department of Physiology and Membrane Biology</institution>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Entomology and Nematology</institution>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Physiology and Membrane Biology</institution>, <institution>University of California Davis Medical Center</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>AnaBios</institution>, <addr-line><named-content content-type="city">San Diego</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>AmbioPharm Inc</institution>, <addr-line><named-content content-type="city">North Augusta</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-34456"><name><surname>Islas</surname><given-names>Leon D</given-names></name><role>Reviewing editor</role><aff><institution>Universidad Nacional Autónoma de México</institution>, <country>Mexico</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hwulff@ucdavis.edu</email> (HW);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>yarovoy@ucdavis.edu</email> (VY);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>12</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e81727</elocation-id><history><date date-type="received"><day>09</day><month>07</month><year>2022</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Nguyen et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Nguyen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81727-v1.pdf"/><abstract><p>The voltage-gated sodium Na<sub>V</sub>1.7 channel plays a key role as a mediator of action potential propagation in C-fiber nociceptors and is an established molecular target for pain therapy. ProTx-II is a potent and moderately selective peptide toxin from tarantula venom that inhibits human Na<sub>V</sub>1.7 activation. Here we used available structural and experimental data to guide Rosetta design of potent and selective ProTx-II-based peptide inhibitors of human Na<sub>V</sub>1.7 channels. Functional testing of designed peptides using electrophysiology identified the PTx2-3127 and PTx2-3258 peptides with IC<sub>50</sub>s of 7 nM and 4 nM for hNa<sub>V</sub>1.7 and more than 1,000-fold selectivity over human Na<sub>V</sub>1.1, Na<sub>V</sub>1.3, Na<sub>V</sub>1.4, Na<sub>V</sub>1.5, Na<sub>V</sub>1.8, and Na<sub>V</sub>1.9 channels. PTx2-3127 inhibits Na<sub>V</sub>1.7 currents in mouse and human sensory neurons and shows efficacy in rat models of chronic and thermal pain when administered intrathecally. Rationally-designed peptide inhibitors of human Na<sub>V</sub>1.7 channels have transformative potential to define a new class of biologics to treat pain.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>UG3NS114956</award-id><principal-award-recipient><name><surname>Nguyen</surname><given-names>Phuong T</given-names></name><name><surname>Nguyen</surname><given-names>Hai M</given-names></name><name><surname>Wagner</surname><given-names>Karen M</given-names></name><name><surname>Stewart</surname><given-names>Robert</given-names></name><name><surname>Singh</surname><given-names>Vikrant</given-names></name><name><surname>Thapa</surname><given-names>Parashar</given-names></name><name><surname>Chen</surname><given-names>Yi-Je</given-names></name><name><surname>Lillya</surname><given-names>Mark W</given-names></name><name><surname>Ton</surname><given-names>Anh Tuan</given-names></name><name><surname>Kondo</surname><given-names>Richard</given-names></name><name><surname>Ghetti</surname><given-names>Andre</given-names></name><name><surname>Pennington</surname><given-names>Michael W</given-names></name><name><surname>Hammock</surname><given-names>Bruce</given-names></name><name><surname>Griffith</surname><given-names>Theanne N</given-names></name><name><surname>Sack</surname><given-names>Jon T</given-names></name><name><surname>Wulff</surname><given-names>Heike</given-names></name><name><surname>Yarov-Yarovoy</surname><given-names>Vladimir</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Phuong T Nguyen, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California.(U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf3"><p>Hai M Nguyen, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California. (U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf4"><p>Karen M Wagner, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California. (U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf5"><p>Anh Tuan Ton, is affiliated with AnaBios Corporation. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf6"><p>Richard Kondo, is affiliated with AnaBios Corporation. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf7"><p>Andre Ghetti, is affiliated with AnaBios Corporation. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf8"><p>Michael W Pennington, is affiliated with Ambiopharm Inc. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf9"><p>Bruce Hammock, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California. (U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf10"><p>Jon T Sack, Reviewing editor, <italic>eLife</italic>.Is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the application no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf11"><p>Heike Wulff, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California. (U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf12"><p>Vladimir Yarov-Yarovoy, is named inventor on a patent application entitled 'Peptides targeting sodium channels to treat pain' based on this research, filed by the University of California. (U.S. provisionalapplication no. 63/358,684, filed July 6, 2022)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Research involving vertebrate animals was done at the University of California following protocols reviewed and approved by the UC Davis Institutional Animal Care and Use Committee (UCD IACUC) - Animal Welfare Assurance Number A3433-01. The animals were cared for by the Center for Laboratory Animal Science (CLAS) Veterinary Services under a currently AAALAC approved program under the direction of Dr. Laura Brignolo (Campus Veterinarian). The animals were housed in NIH-approved facilities in CLAS and are observed daily by technicians. Unusual events are reported to the on call veterinarian, as well as to the investigator according to posted protocols. Other maintenance veterinary care was conducted according to NIH guidelines on the Use and Care of Animals. Facilities were inspected regularly according to NIH and AAALAC guidelines.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript.</p></sec><supplementary-material><ext-link xlink:href="elife-81727-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>